Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2023-04-23 Report Publication Anno…
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
关于变更2023年一季度报告披露时间的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (422 characters) from a company about changing the disclosure date of its 2023 first quarter report. It does not contain the actual quarterly report or financial data, but only informs about the timing adjustment of the report release. According to the 'MENU VS MEAL' rule, such a brief notice about report timing is classified as a Report Publication Announcement (RPA), not as the Interim/Quarterly Report (IR) itself.
2023-04-23 Chinese
关于完成工商变更登记并换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Sichuan Zitonggong Pharmaceutical Co., Ltd. regarding the completion of business registration changes and the reissuance of the business license. It details the approval of changes in the company's business scope and amendments to the articles of association, as well as the completion of the registration with the market supervision authority. The document is short (976 characters) and serves as a formal notice of these administrative changes rather than a financial report or detailed management information. It does not contain financial data, audit information, or meeting materials. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous official announcements that do not fit other specific categories.
2023-04-16 Chinese
重要在研产品取得药品注册批件的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the approval of a drug registration certificate for an in-development product. It includes details about the product, its intended use, and the impact on the company, along with risk warnings. The document is short (928 characters) and serves as an announcement of a milestone achievement rather than a detailed financial report or regulatory filing. It does not contain financial statements, audit information, or detailed management discussion. It is not a report publication announcement since it is the actual announcement of the product approval. The content fits best under a general regulatory announcement category, as it informs investors and the public about a significant development related to the company's product pipeline and regulatory approval status. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-04-16 Chinese
2023年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2023 second extraordinary general meeting of shareholders of Sichuan Zitonggong Pharmaceutical Co., Ltd. It includes details about the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the voting results and decisions made at the shareholders' meeting rather than the meeting materials or presentations themselves. The document length is short (1324 characters) and it is clearly a declaration of voting results from a shareholder meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-04-12 Chinese
上海天璇律师事务所关于四川梓橦宫药业股份有限公司2023年第二次临时股东大会的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the procedural legality of a company's 2023 second extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or performance data but focuses on the legality and validity of the meeting process and voting outcomes. It is not an announcement of voting results per se but a legal opinion on the meeting's procedural compliance. Given the nature of the document as a legal opinion on a shareholders' meeting, it fits best under Legal Proceedings Report (LTR) rather than Declaration of Voting Results (DVA) or Regulatory Filings (RNS). The document length is about 3000 characters, which is not extremely short, and it is not a mere announcement or certification. Therefore, the classification is Legal Proceedings Report (LTR) with high confidence.
2023-04-12 Chinese
关于拟修订《公司章程》的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the proposed amendments to the company's Articles of Association (公司章程). It details specific changes to the company's business scope and states that these changes require shareholder approval. The document is a formal announcement of corporate governance changes but does not contain financial data, audit information, or detailed management reports. It is not a full report but a regulatory announcement about governance changes. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in company governance documents or management-related matters.
2023-03-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.